| 2024-03 |
Inhibition of the Alternative Complement Pathway May Cause Secretion of Factor B, Enabling an Early Detection of Pancreatic Cancer |
Journal of Proteome Research
|
| 2024-02 |
Large Language Models: A Guide for Radiologists |
Korean Journal of Radiology
|
| 2024-01 |
Open-Label, Multicenter, Randomized, Biomarker-Integrated Umbrella Trial for Second-Line Treatment of Advanced Gastric Cancer: K-Umbrella Gastric Cancer Study |
Journal of Clinical Oncology
|
| 2024-01 |
Second-line chemoimmunotherapy with nivolumab and paclitaxel in immune-related biomarker-enriched advanced gastric cancer: a multicenter phase Ib/II study |
Gastric Cancer
|
| 2023-11 |
Prior antibiotic administration disrupts anti-PD-1 responses in advanced gastric cancer by altering the gut microbiome and systemic immune response |
Cell Reports Medicine
|
| 2023-10 |
Clinicopathological Characteristics of NRG1 Fusion-Positive Solid Tumors in Korean Patients |
Cancer Research and Treatment
|
| 2023-10 |
Impact of Coronavirus Disease 2019 on Gastric Cancer Diagnosis and Stage: A Single-Institute Study in South Korea |
Journal of Gastric Cancer
|
| 2023-10 |
ARID1A Mutation from Targeted NGS Predicts Primary Resistance to Gemcitabine and Cisplatin Chemotherapy in Advanced Biliary Tract Cancer |
Cancer Research and Treatment
|
| 2023-09 |
Monitoring the Outcomes of Systemic Chemotherapy Including Immune Checkpoint Inhibitor for HER2-Positive Metastatic Gastric Cancer by Liquid Biopsy |
Yonsei Medical Journal
|
| 2023-09 |
Trastuzumab Combined With Ramucirumab and Paclitaxel in Patients With Previously Treated Human Epidermal Growth Factor Receptor 2–Positive Advanced Gastric or Gastroesophageal Junction Cancer |
Journal of Clinical Oncology
|
| 2023-07 |
Clinical relevance of clonal hematopoiesis and its interference in cell-free DNA profiling of patients with gastric cancer |
Clinical Chemistry and Laboratory Medicine
|
| 2023-07 |
Immunogenicity and Safety of Vaccines Against Coronavirus Disease in Actively Treated Patients with Solid Tumors: A Prospective Cohort Study |
Cancer Research and Treatment
|
| 2023-06 |
Care Needs of Adolescents and Young Adults with Cancer Undergoing Active Treatment in South Korea: A Mixed Methods Study |
Journal of Adolescent and Young Adult Oncology
|
| 2023-01 |
Trastuzumab plus FOLFOX for HER2-positive biliary tract cancer refractory to gemcitabine and cisplatin: a multi- institutional phase 2 trial of the Korean Cancer Study Group (KCSG-HB19-14) |
The Lancet Gastroenterology & Hepatology
|
| 2022-12 |
Analytical and Clinical Validation of Cell-Free Circulating Tumor DNA Assay for the Estimation of Tumor Mutational Burden |
Clinical chemistry
|
| 2022-10 |
A single arm phase Ib/II trial of first-line pembrolizumab, trastuzumab and chemotherapy for advanced HER2-positive gastric cancer |
NATURE COMMUNICATIONS
|
| 2022-09 |
The UGT1A9*22 genotype identifies a high-risk group for irinotecan toxicity among gastric cancer patients |
Genomics and Informatics
|
| 2022-09 |
Hyperprogressive disease during PD-1 blockade in patients with advanced gastric cancer |
EUROPEAN JOURNAL OF CANCER
|
| 2022-07 |
Could We Predict the Response of Immune Checkpoint Inhibitor Treatment in Hepatocellular Carcinoma? |
Cancers
|
| 2022-07 |
Dll4 Inhibition Promotes Graft Retention in Fat Grafting Enriched with Adipose-Derived Stem Cells |
Stem cells translational medicine
|
| 2022-06 |
Neoadjuvant FOLFIRINOX Followed by Pancreatoduodenectomy for Pancreatic Cancer in Patients with Previous Transhiatal Esophagectomy for Esophageal Cancer |
Case Reports in Oncology
|
| 2022-05 |
Real-world efficacy and safety of cabozantinib in Korean patients with advanced hepatocellular carcinoma: a multicenter retrospective analysis |
Therapeutic Advances in Medical Oncology
|
| 2022-02 |
Curative intent radical cholecystectomy followed by hyperthermic intraperitoneal chemotherapy in ruptured intraductal papillary neoplasm of gallbladder with invasive carcinoma |
Annals of Hepato-Biliary-Pancreatic Surgery
|
| 2022-02 |
Combined tumor epithelial and stromal histopathology with keratin 81 expression predicts prognosis for pancreatic ductal adenocarcinoma |
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES
|
| 2021-12 |
Early Diagnostic Ability of Human Complement Factor B in Pancreatic Cancer Is Partly Linked to Its Potential Tumor-Promoting Role |
JOURNAL OF PROTEOME RESEARCH
|
| 2021-11 |
Deep-Learning-Based Natural Language Processing of Serial Free-Text Radiological Reports for Predicting Rectal Cancer Patient Survival |
FRONTIERS IN ONCOLOGY
|
| 2021-10 |
Molecular Characterization of Biliary Tract Cancer Predicts Chemotherapy and PD-1/PD-L1 Blockade Responses |
HEPATOLOGY
|
| 2021-08 |
Real-world efficacy and safety of nab-paclitaxel plus gemcitabine-cisplatin in patients with advanced biliary tract cancers: a multicenter retrospective analysis |
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
|
| 2021-06 |
Distinct characteristics and clinical outcomes to predict the emergence of met amplification in patients with non-small cell lung cancer who developed resistance after treatment with epidermal growth factor receptor tyrosine kinase inhibitors |
Cancers
|
| 2021-05 |
The Awareness and Usage of Big Data for Cancer in Korea: A Survey Study |
보건정보통계학회지
|
| 2021-05 |
Prediction of Immune-Checkpoint Blockade Monotherapy Response in Patients With Melanoma Based on Easily Accessible Clinical Indicators |
FRONTIERS IN ONCOLOGY
|
| 2021-02 |
Liposomal irinotecan plus fluorouracil/leucovorin versus FOLFIRINOX as the second-line chemotherapy for patients with metastatic pancreatic cancer: a multicenter retrospective study of the Korean Cancer Study Group (KCSG) |
ESMO OPEN
|
| 2015-06 |
Correlation Analysis and Prognostic Impact of 18F-FDG PET and Excision Repair Cross-Complementation Group 1 (ERCC-1) Expression in Non-Small Cell Lung Cancer |
Nuclear Medicine and Molecular Imaging
|